Johnson & Johnson Deferred Tax Assets decreased by 2.0% to $6.67B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 28.7%, from $9.35B to $6.67B. Over 3 years (FY 2021 to FY 2024), Deferred Tax Assets shows relatively stable performance with a -0.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests the company has more 'tax shields' to protect future earnings, while a valuation allowance against them would signal doubt about future profitability.
An asset on the balance sheet that results from overpayment or advance payment of taxes, or from carryforwards of losses...
Companies with significant R&D operations typically carry higher deferred tax assets due to government incentives for innovation.
deferred_tax_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.32B | $10.80B | $10.65B | $10.22B | $9.94B | $9.51B | $9.12B | $8.82B | $9.26B | $9.28B | $10.31B | $9.00B | $9.35B | $10.46B | $8.49B | $6.80B | $6.67B |
| QoQ Change | — | +29.8% | -1.5% | -4.0% | -2.8% | -4.2% | -4.1% | -3.4% | +5.0% | +0.2% | +11.1% | -12.6% | +3.8% | +11.9% | -18.8% | -19.9% | -2.0% |
| YoY Change | — | — | — | — | +19.4% | -11.9% | -14.3% | -11.3% | -2.7% | +1.7% | — | +2.1% | +1.0% | +12.7% | -17.6% | -24.5% | -28.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.